Skip to main content
Equibles

MARSHALL WACE, LLP

Position in ANIK — Anika Therapeutics, Inc.

CIK 1318757 LONDON, X0
Back to ANIK Full portfolio

Position in ANIK

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$320,660
-$26,339 QoQ
Shares Held
21,918
-8.4% QoQ
Ownership
0.164%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 134 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names. ANIK ranks #27 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HIMS
Hims & Hers Health, Inc.
 4,217,767 $146,229,981
2 ELAN
Elanco Animal Health Inc
 4,432,350 $109,080,132
3 LNTH
Lantheus Holdings, Inc.
 773,978 $85,865,119
4 ALKS
Alkermes plc.
 969,954 $50,825,589
5 NBIX
Neurocrine Biosciences Inc
 270,754 $45,632,878
6 RDY
Dr Reddys Laboratories Ltd
 2,025,356 $29,347,408
7 AMPH
Amphastar Pharmaceuticals, Inc.
 1,066,322 $21,518,377
8 ZTS
Zoetis Inc.
 257,470 $18,501,794

All Filings in ANIK

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $320,660 21,918
2026-03-31 $346,999 23,931
2025-12-31 $837,876 87,188
2025-09-30 $693,005 73,724
2025-06-30 $241,033 22,782
2024-12-31 $171,611 10,426
2024-09-30 $404,610 16,381
2024-06-30 $704,528 27,814
2024-03-31 $871,016 34,292
2023-12-31 $466,161 20,572
2022-12-31 $469,012 15,845
2022-06-30 $1,034,375 46,343
2021-09-30 $405,852 9,536
2021-03-31 $545,892 13,383
2020-03-31 $178,577 6,177